Biotech

All Articles

Lilly, Haya ink $1B biobuck excessive weight treaty to browse darker genome

.Eli Lilly's look for excessive weight aim ats has led it to the black genome. The Big Pharma has ac...

ArsenalBio increases $325M, pivots out of previous lead possession

.Arsenal Biosciences is actually proceeding up. The tissue treatment company has actually added on $...

Lilly- supported effective weight loss biotech reports IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' marijuana use drug flunks phase 2b, driving Indivior to re-think $100M possibility

.Aelis Farma's hopes of safeguarding a simple, good selection on a $100 thousand choice settlement h...

ProKidney standstills stage 3 test not required for tissue therapy approval

.ProKidney has stopped one of a set of phase 3 trials for its own cell treatment for kidney disease ...

Vaxcyte rises on 'impressive' 31-valent PCV win versus Pfizer

.Vaxcyte unveiled what analysts referred to as "remarkable" period 1/2 information for its own 31-va...

Recursion's human brain illness trial presents little proof of efficacy

.Recursion has actually stumbled via a very early exam of its tech-enabled technique to medicine dis...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Phone it a situation of really good chemical make up: Acepodia, a biotech based on Nobel Champion s...

Praxis epilepsy drug minimizes seizures in phase 2 hearing

.Practice Precision Medicines has actually racked up one more midphase succeed in epilepsy this year...

Three execs surrender as Dyne blog posts blended records for DMD applicant

.After getting away from a professional hold numerous years back, Dyne Therapeutics has uncovered br...